At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...

For the past several years, pharmaceutical giant Pfizer has been under investigation by the U.S. Department of Justice for ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that senior executives at the pharma ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

Pfizer (PFE) closed at $25.32 in the latest trading session, marking a +1.12% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.48% for the day. Elsewhere, the Dow ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

The House Judiciary Committee subpoenaed a former Pfizer Inc. executive, demanding he address allegations of deliberately ...

Mumbai: Pfizer has announced the appointment of Reshma Parida as the new Senior Director - People Experience, effective ...

(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...